DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD
SIWA Therapeutics, Inc., a privately held biotechnology company developing a family of monoclonal antibodies to prevent, slow or reverse aging, aging-related and degenerative diseases by reducing senescent cells, announced today that Dr. Thomas Tang has joined its Scientific Advisory Board. Dr. Tang is the CEO of First Dimension BioSciences, a genetic information database company focusing on cancer genomes to establish a statistical compendium of mutation profiles in a state-of-the-art computational data center. He has over 20 years of experience in genomics and bioinformatics research. “Dr. Tang’s addition to the SIWA team will resurrect a productive past partnership,” said Lewis Gruber, co-founder and chief executive officer of SIWA. ‘Tom was one of the early scientists at my first company, Hyseq, Inc. He was a key player in developing Hyseq’s genomics database…